Divi's Labs announces dividend TDS details for FY26

Divi's Laboratories announces dividend TDS details for FY26. The company has informed the exchange about the deduction of income tax at source from dividend payments for FY2025-26. This is a routine compliance disclosure related to dividend disbursement. No financial impact on operations or earnings is expected.

📊 STOCKS: DIVISLAB | 🏢 SECTOR: Pharma | #LOWIMPACT #Dividend